Last reviewed · How we verify

NCT04198194

Apple Heart & Movement Study

Active, enrolled Last updated 21 February 2025
What this trial tests

trial testing Predictors of events in Prevention in 500,000 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
14 November 2019
Primary endpoint
28 February 2025
28 February 2025

Quick facts

Lead sponsorApple Inc.
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment500,000
Start date14 November 2019
Primary completion28 February 2025
Estimated completion28 February 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Apple Inc. — full company profile →

Who can join

18 and older, any sex, with Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will look for factors that affect heart health and potentially cause deterioration in mobility or heart function. Participant's Apple Watch and iPhone can help researchers gain a better understanding of potential early warning signs. This can lead to new interventions and products that will help millions lead longer, healthier, and more active lives.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Pulse oximetry values from 33,080 participants in the Apple Heart & Movement Study.
    Shapiro I, Stein J, MacRae C, O'Reilly M. · · 2023 · cited 11× · PMID 37500721 · DOI 10.1038/s41746-023-00851-6
  2. Modeling personalized heart rate response to exercise and environmental factors with wearables data.
    Nazaret A, Tonekaboni S, Darnell G, Ren SY, et al · · 2023 · cited 10× · PMID 37968567 · DOI 10.1038/s41746-023-00926-4
  3. Understanding activity and physiology at scale: The Apple Heart & Movement Study.
    Truslow J, Spillane A, Lin H, Cyr K, et al · · 2024 · cited 9× · PMID 39256546 · DOI 10.1038/s41746-024-01187-5
  4. A wearable-based aging clock associates with disease and behavior.
    Miller AC, Futoma J, Abbaspourazad S, Heinze-Deml C, et al · · 2025 · cited 1× · PMID 41115881 · DOI 10.1038/s41467-025-64275-4
  5. Naturalistic sleep tracking in a longitudinal cohort: Uncertainty and bias in short duration sampling.
    Goparaju B, de Palma G, Bianchi MT. · · 2025 · PMID 41183052 · DOI 10.1371/journal.pone.0334950
  6. Deep sleep homeostatic response to naturalistic sleep loss.
    Goparaju B, Ravindran S, Bianchi MT. · · 2025 · PMID 41052109 · DOI 10.1371/journal.pdig.0001021

Verify or expand the search:

Other recruiting trials for Prevention

Currently open trials in the same condition.

Other Apple Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04198194.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing